|
|
|
Poster presentations on studies in cutaneous T-cell, peripheral T-cell and B-cell lymphoma-- Gloucester Pharmaceuticals today announced multiple presentations from clinical and preclinical studies of ISTODAX® (romidepsin) at...
Incyte Corporation (NASDAQ: INCY) announced today that it has entered into a collaboration and license agreement with Novartis for two of its investigational hematology-oncology therapies: INCB18424, an oral JAK1/JAK2 inhibitor...
Nov 24, 2009 (M2 PRESSWIRE via COMTEX) -- Stocks in the News: The9 Limited (Nasdaq: NCTY), Riverdale Capital Ltd. (OTC: RICP), YM BioSciences Inc. (AMEX: YMI), Atwood Oceanics Inc., (NYSE: ATW) and China Forestry Inc., (OTCBB:...
PA-Harrisburg, Medical Director of Transfusion Medicine - Clinical Pathology Medical Director of Transfusion Medicine - Clinical Pathology - Blood Bank - Board Certified - BCBE - Skills Required - Clinical Pathology, Medical...
INDIANAPOLIS Involving family members of pediatric cancer and hematology patients in medical rounds benefits both the family and the medical team, according to a new Indiana University School of Medicine study. Riley Hospital...
WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ — The American Society of Hematology (ASH) and Scholastic, the global children's publishing, education, and media company, are launching "Explore the Mystery of Blood," a dynamic...
MISSISSAUGA, ON, Nov. 23 /PRNewswire-FirstCall/ -- YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products...
The haematologist, pathologist and oncologist Humphrey Kay was best known for pioneering a scientific approach to the diagnosis and treatment of leukaemia. It is the most common form of childhood cancer although it affects...
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that the Company and collaborating investigators from five major oncology research centers in the United States will present data from a Phase 1 clinical trial of...
A new study, 'Random serum methotrexate determinations for assessing compliance with maintenance therapy for childhood acute lymphoblastic leukemia,' is now available. According to recent research published in the journal...
